QA: Cell Source Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001569340_2023_Cell_Source_Inc.pdf

Logs

warning Similarly named company. Duplicate? None {'details': [{'other_company': 'International Stem Cell CORP', 'shared_tokens': {'cell'}}]}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001569340, Cell Source Inc.

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 409,845
4 LiabilitiesCurrent 680,325
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 12,363,415
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,179,160
9 ResearchAndDevelopmentExpense 1,938,173
10 remainder_Expenses 58,000
11 remainder_Revenues 0
12 remainder_NetIncome -992,415
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 409,845
1 Liabilities 13,043,740
2 Expenses 4,175,333
3 Revenues 0
4 StockholdersEquity -12,633,895
5 NetIncome -5,167,748
6 ComprehensiveNetIncome -5,167,748
7 BaseVar 9,310,666
8 EconomicCapitalRatio -4.00

Edgar->Model Mapping

Feature Distribution

Change over Time